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A Multicenter Study Investigating the Factors the Influence Participation in Clinical Research:
A Focus on the Mindsets of Pregnant and Fertile Women
Meredith Kalberer; Anita Kurt, PhD, RN
Lehigh Valley Health Network, Allentown, Pennsylvania

OVERVIEW

SUSPECTED INFLUENCES

The Multi-center Study focuses on investigating
factors that influence female participation in clinical
research. The goal is to understand female patient’s
perspectives about research that lead to the gender
disparity and to gain enough insight to overcome
potential barriers.
GOALS:
Investigate female patient’s overall mindset about
clinical research
Recognize factors and resources that can help
influence participation using a 0-4 Ascending Scale.
(0=No motivation, 1= Very little motivation, 2=Some motivation, 3=Significant
motivation, 4=Most motivation)

1. In 1977, the FDA banned all women of child bearing potential from
participating in clinical research.1
-This could have cause a continuing stigma concerning
participation.
2. Women with child bearing capabilities or who are already pregnant
may view risks to their health differently than those women who can no
longer have children.
- Different resources may influence each groups participation.
3. Women who are still creating and overseeing a family may feel
obligated to spend more time on this.
-A Barrier, such as time, is a simple explanation of the gender
disparity in research and can be remedied.

Begin to bridge gaps in clinical research concerning
gender
The results of this specific research will aim to identity
any differences between pregnant and fertile women’s
barriers concerning clinical research.
Outcomes indicate that a stigma may be influencing
fertile women’s decision making and that pregnant and
fertile women have different factors that influence their
participation. Overall, women are open to participating
in clinical research, if approached correctly.

CONCLUSIONS

RESULTS

* Fertility is defined as less than 40 years of age for the purpose of this data analysis

Table 1: summary of the 400 women who completed
the surveys used in this analysis

Pregnant

NonPregnant

n=217

n=167

Fertile

Non-Fertile

n=323

n=53

Chart 1: shows the different groups compared
during data analysis
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STARTING THE CHANGE
After the data analysis of all of the sites, even clearer
influences about female participation will be recognized
Until the time when participation between men and women
is equal, or appropriate participation in gender based diseases is
acceptable, change needs to be worked for. This can be done by:
1. Making sure women are aware of the disparity. Education is key.
2. Use this study’s final findings to influence women in a positive
way to participate.
3. Encourage guidelines to be passed by the government or FDA in
order to define what is a “reasonable” number of women
participating in clinical studies, This can be used to guide
organizations that fund research.2

Table 2: shows
statistically
significant
results when
comparing the
groups opinions
of factors. The
group that
favored the
factor is listed.

METHODS

Table 1 shows the general statistics of the 400 female participants whose
data was used for this analysis. The age range was from 18 to 76 years old,
over half the women surveyed were pregnant at the time, and about 86% of
the women were still of fertile age (defined as less than 40 years old.) Less
than 6% of women surveyed had participated in clinical research before.
I.
The top motivating factor for all factions of women was “How well the
research is explained”. The top barrier was “Risk of unknown side
effects for fertile, non-fertile, and non-pregnant women. Pregnant
women feel “Risk to fetus/future fertility” is the greatest barrier. The top
resource for all factions was “Having material provided in my own
language.
II. Non- fertile women feel that knowledge gained from their participation
is more important than fertile women (p=0.0225). See table 2
III. Both pregnant/non-pregnant women and fertile/non-fertile women,
disagreed about the importance of “Risk to fetus/future fertility” as a
barrier (p=0.0004, p=0.0133). See table 2 *Note some non-fertile
women still voted this barrier as “4”, pointing out a potential stigma in
their minds about clinical research.
IV. Fertile and non-fertile women have statistically significant opinions
about the helpfulness of “Written material explaining the research
study” and “Having material provided in my own language” (p=0.0459).
See table 2
The outcomes indicate women are open to clinical research and
potential resources, but different approaches may be helpful when
recruiting women. A stigma may still exist and must be confronted.

Figure 1: shows the total of
“4” votes each resources
received, separated by the 4
separate groups of women
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